Literature DB >> 22083489

The class A β-lactamase FTU-1 is native to Francisella tularensis.

Nuno T Antunes1, Hilary Frase, Marta Toth, Sergei B Vakulenko.   

Abstract

The class A β-lactamase FTU-1 produces resistance to penicillins and ceftazidime but not to any other β-lactam antibiotics tested. FTU-1 hydrolyzes penicillin antibiotics with catalytic efficiencies of 10(5) to 10(6) M(-1) s(-1) and cephalosporins and carbapenems with catalytic efficiencies of 10(2) to 10(3) M(-1) s(-1), but the monobactam aztreonam and the cephamycin cefoxitin are not substrates for the enzyme. FTU-1 shares 21 to 34% amino acid sequence identity with other class A β-lactamases and harbors two cysteine residues conserved in all class A carbapenemases. FTU-1 is the first weak class A carbapenemase that is native to Francisella tularensis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083489      PMCID: PMC3264220          DOI: 10.1128/AAC.05305-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 2.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors:  E B Chaïbi; D Sirot; G Paul; R Labia
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

3.  ExPASy: The proteomics server for in-depth protein knowledge and analysis.

Authors:  Elisabeth Gasteiger; Alexandre Gattiker; Christine Hoogland; Ivan Ivanyi; Ron D Appel; Amos Bairoch
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Francisella tularensis bacteremia.

Authors:  X Haristoy; A Lozniewski; C Tram; D Simeon; L Bevanger; C Lion
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry.

Authors:  Hilary Frase; Clyde A Smith; Marta Toth; Matthew M Champion; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

Review 6.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.

Authors:  J R Knox
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Isolation of Francisella tularensis by centrifugation of shell vial cell culture from an inoculation eschar.

Authors:  P E Fournier; L Bernabeu; B Schubert; M Mutillod; V Roux; D Raoult
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

Authors:  Hesna Yigit; Anne Marie Queenan; J Kamile Rasheed; James W Biddle; Antonio Domenech-Sanchez; Sebastian Alberti; Karen Bush; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  First isolation of Francisella tularensis subsp. tularensis in Europe.

Authors:  D Gurycová
Journal:  Eur J Epidemiol       Date:  1998-12       Impact factor: 8.082

10.  Molecular characterization of a carbapenem-hydrolyzing class A beta-lactamase, SFC-1, from Serratia fonticola UTAD54.

Authors:  Isabel Henriques; Alexandra Moura; Artur Alves; Maria José Saavedra; António Correia
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

View more
  17 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Class A carbapenemase FPH-1 from Francisella philomiragia.

Authors:  Marta Toth; Viktoria Vakulenko; Nuno T Antunes; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

3.  CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens.

Authors:  Elizabeth Pursey; Tatiana Dimitriu; Fernanda L Paganelli; Edze R Westra; Stineke van Houte
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-11-29       Impact factor: 6.237

4.  Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6.

Authors:  Toni L Lamoureaux; Hilary Frase; Nuno T Antunes; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

5.  A novel extended-spectrum β-lactamase, SGM-1, from an environmental isolate of Sphingobium sp.

Authors:  Toni L Lamoureaux; Viktoria Vakulenko; Marta Toth; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

6.  In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods.

Authors:  Henry S Heine; Lynda Miller; Stephanie Halasohoris; Bret K Purcell
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

7.  Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.

Authors:  Jean-Marie Pagès; Sabine Peslier; Thomas A Keating; Jean-Philippe Lavigne; Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

8.  A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis.

Authors:  Vivien Sutera; Yvan Caspar; Sandrine Boisset; Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2014-03-18       Impact factor: 5.293

9.  Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.

Authors:  Yvan Caspar; Vivien Sutera; Sandrine Boisset; Jean-Noël Denis; Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2014-02-27       Impact factor: 5.293

Review 10.  New therapeutic approaches for treatment of tularaemia: a review.

Authors:  Sandrine Boisset; Yvan Caspar; Vivien Sutera; Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2014-03-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.